1. Home
  2. CTRI vs ARQT Comparison

CTRI vs ARQT Comparison

Compare CTRI & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTRI
  • ARQT
  • Stock Information
  • Founded
  • CTRI 1909
  • ARQT 2016
  • Country
  • CTRI United States
  • ARQT United States
  • Employees
  • CTRI N/A
  • ARQT N/A
  • Industry
  • CTRI
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTRI
  • ARQT Health Care
  • Exchange
  • CTRI Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • CTRI 1.3B
  • ARQT 1.1B
  • IPO Year
  • CTRI 2024
  • ARQT 2020
  • Fundamental
  • Price
  • CTRI $20.41
  • ARQT $9.26
  • Analyst Decision
  • CTRI Hold
  • ARQT Strong Buy
  • Analyst Count
  • CTRI 7
  • ARQT 5
  • Target Price
  • CTRI $18.50
  • ARQT $14.40
  • AVG Volume (30 Days)
  • CTRI 464.7K
  • ARQT 2.4M
  • Earning Date
  • CTRI 11-06-2024
  • ARQT 11-06-2024
  • Dividend Yield
  • CTRI N/A
  • ARQT N/A
  • EPS Growth
  • CTRI N/A
  • ARQT N/A
  • EPS
  • CTRI N/A
  • ARQT N/A
  • Revenue
  • CTRI $2,585,466,000.00
  • ARQT $138,708,000.00
  • Revenue This Year
  • CTRI N/A
  • ARQT $208.32
  • Revenue Next Year
  • CTRI $5.71
  • ARQT $48.56
  • P/E Ratio
  • CTRI N/A
  • ARQT N/A
  • Revenue Growth
  • CTRI N/A
  • ARQT 182.84
  • 52 Week Low
  • CTRI $14.47
  • ARQT $1.76
  • 52 Week High
  • CTRI $28.65
  • ARQT $13.17
  • Technical
  • Relative Strength Index (RSI)
  • CTRI N/A
  • ARQT 46.45
  • Support Level
  • CTRI N/A
  • ARQT $8.29
  • Resistance Level
  • CTRI N/A
  • ARQT $10.76
  • Average True Range (ATR)
  • CTRI 0.00
  • ARQT 0.66
  • MACD
  • CTRI 0.00
  • ARQT 0.09
  • Stochastic Oscillator
  • CTRI 0.00
  • ARQT 32.51

About CTRI Centuri Holdings Inc. Common Stock

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings primarily consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. They operate under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: